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Abstract
The ECUAVIDA birth cohort is studying the impact of exposures to soil-transmitted
helminth (STH) parasites and early-life microbial exposures on the development of
atopy, allergic diseases and immune responses in childhood. A total of 2404 newborns
were recruited between 2006 and 2009 in a public hospital serving the rural district of
Quininde, Esmeraldas Province, in a tropical region of coastal Ecuador. Detailed meas-
urements were done around the time of the birth, at 7 and 13 months and at 2 and 3
years, and data collection is ongoing at 5 and 8 years. Data being collected include ques-
tionnaires for: sociodemographic, lifestyle, psychosocial (at 4–6 years only) and dietary
(at 6–7 years only) factors; childhood morbidity and clinical outcomes; stool samples for
parasites; blood samples for DNA, measurements of vaccine responses and other meas-
ures of immune function/inflammation; and anthropometrics. Allergen skin prick test
reactivity is done from 2 years and measures of airway function and inflammation at 8
years.
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Cohort Profile
Why was the cohort set up?
Chronic infections with helminth parasites are associated
with the induction of immune tolerance, an effect that may
contribute to the regulation of host inflammation and a re-
duction in the risk of inflammatory diseases such as those
associated with allergy.1,2
The most common helminth infections are those caused
by the soil-transmitted helminths (STH) including Ascaris
lumbricoides, Trichuris trichiura and hookworm, that are
estimated to infect 2 billions worldwide. These parasites
are considered to have important effects on nutrition
and growth in childhood3 and are particularly common
among children living in poverty in the warm moist
tropics where conditions are optimal for survival and
transmission of these parasites through contact with a
faecally-contaminated environment.
The apparent low prevalence of atopy and allergic dis-
eases reported from the rural tropics may be explained by
the high prevalence of these parasites in children:1,4 al-
though helminth infections can induce allergic-type re-
sponses in the human host,2,5 such responses are strongly
regulated during chronic infections2,6 and may contribute
to a reduction in inflammatory responses to aeroallergens.6
Cross-sectional epidemiological studies of schoolchil-
dren have shown an inverse association between the pres-
ence of STH infections and the prevalence of skin prick test
(SPT) reactivity to aeroallergens.2,7 The effects of STH
infections on allergic symptoms are less clear. A meta-
analysis of observational studies suggested that hookworm
infection was associated with a reduced, but Ascaris with
an increased, prevalence of asthma symptoms.8 Several
cross-sectional studies have measured the effects of STH
infections on the prevalence of eczema and rhinitis, show-
ing variable effects,7 but recent studies have provided little
evidence for an association.9,10
Reductions in morbidity caused by STH infections gen-
erally require periodic mass treatments with anthelmintic
drugs because re-infection rates are high in endemic re-
gions.11 Randomized intervention studies of the effects of
periodic anthelmintic treatments on allergic outcomes in
schoolchildren have provided conflicting evidence, with
some showing a post-treatment increase in SPT inci-
dence12, or prevalence13 whereas others have shown no
effect.14–16 An analysis of data from communities in
Ecuador that had received community-wide anthelmintic
treatments for a period of 15 years showed that such treat-
ments were associated with an increase in the prevalence of
SPT and eczema in schoolchildren.17 Because the interven-
tion was implemented before the children were born, and
would have reduced STH exposures during early life (i.e.
through a reduction in maternal and early childhood infec-
tions), these data could be interpreted to suggest that early
exposures are critical for the protective effect.18 A random-
ized controlled study in Uganda showed an increased inci-
dence of eczema to 5 years of age among offspring of
mothers treated with anthelmintics during pregnancy.19,20
The protective effects of environmental exposures against
allergy appear to be stronger when present in early child-
hood21,22 or even in utero,23 such as those associated with
farming.
We, therefore, started a birth cohort in a rural district
of Ecuador, endemic for STH parasites, to observe the ef-
fects of early exposures to STH infections on the develop-
ment of atopy and allergic disease. The cohort also
provides the opportunity to investigate the possible effects
of other microbial and environmental exposures in early
childhood on the development of atopy and allergic
diseases.24
What does the study cover?
The ECUAVIDA cohort is a prospective cohort study from
birth, designed to investigate the effects of pre- and postna-
tal exposures to STH parasites on the development of
Key Messages
• Maternal STH infections, the primary study exposure, were observed in 45.9% of mothers during pregnancy.
• The cohort children had a high risk of infection with STH and protozoal parasites during the first 2 years of life: 28.6%
of children had at least one documented STH infection.
• An active surveillance sample within the cohort is being used to estimate the burden of infection with a wide
range of enteric and respiratory infections during the first 3 years of life. For example, a peak incidence of norovirus
of 75.7 infections / 100 person-years was observed between 6 and11 months of age.
• Any episode of eczema by 3 years of age was observed in 17.7% of 2069 cohort children with complete data; 25.9%
had wheeze and 17.1% had skin test reactivity to any aeroallergen.
• Immunological analyses have shown that maternal STH infections sensitize the fetal immune response to STH antigens,
and that the innate immune response at 2 years does not differ markedly from that observed in affluent countries.
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atopy and allergic diseases to 8 years of age. The study is
one of few rural birth cohorts from a developing country—
to our knowledge it is the only such cohort being
conducted in a rural region of Latin America currently in
progress—and provides the opportunity to investigate the
role of the hygiene hypothesis more generally through an
examination of the effects of a variety of infectious, micro-
bial and environmental exposures on the development of
study outcomes. The study population is undergoing the
rapid transition from a more traditional rural to an urban
way of living and provides the opportunity also to examine
the processes associated with this transition on study out-
comes. Because diabetes mellitus and cardiovascular and
hypertensive disease have emerged as three major causes of
death in Ecuadorian adults,25 and these outcomes have
been associated with chronic low-grade inflammation26,27
and are considered to start in early life,26–28 we have
included the measurement of clinical indices and bio-
markers for these diseases in the cohort to allow us to
evaluate the effects on the development of infection and
inflammation in early childhood.
The general aims of the project are:
i. to measure the impact of prenatal (maternal infections)
and postnatal infections with STH parasites on the
development of atopy and allergic diseases;
ii. to explore the effects of other chronic infections and
microbial exposures in early childhood on the develop-
ment of atopy and allergic diseases;
iii. to explore the effects of chronic infections and micro-
bial exposures on the development of the immune
response in childhood, including vaccine immune
responses;
iv. to explore the effects of early-life infections and
inflammation on growth and nutritional trajectories
during childhood;
v. to explore the effects of early-life exposures, both
infectious and non-infectious, on the development of
allergic diseases and markers for chronic non-
communicable diseases (e.g. blood pressure and
plasma glucose) during childhood.
Who is in the cohort?
The study population included eligible newborns delivered
at the Hospital Padre Alberto Buffoni (HPAB) between
November 2006 and December 2009. HPAB is the only
hospital serving the rural district of Quininde´, Esmeraldas
Province, Ecuador (Figure 2). During recruitment, mem-
bers of the study team visited daily the maternity and vac-
cination departments of HPAB. Inclusion criteria were: (i)
healthy baby less than 14 days old; (ii) at least one stool
sample collected from the mother in the third trimester of
pregnancy or around the time of delivery of the child; (iii)
the family has lived in the district of Quininde´ for the last
2 years and does not plan to move out of the district over
the following 3 years; (iv) the home was accessible; and (v)
the family has no ethical or religious principles that might
interfere with their participation. Mothers were initially
interviewed for eligibility and, if interested and eligible, a
home visit was scheduled where informed written consent
was obtained and a standardized questionnaire adminis-
tered. The mothers of 2404 eligible newborns agreed to
participate in the study. Reasons for non-participation are
shown in Figure 1. The district of Quininde´ is primarily de-
pendent economically on agriculture. Within the district
are three towns with populations greater than 10 000 inhab-
itants: Quininde´, La Union and La Concordia. About 70%
of the cohort lives in rapidly expanding urban and peri-urban
neighbourhoods of these three towns, and the remainder in
rural recintos (or settlements). The distribution of study
households of cohort children in the district of Quininde´ is
shown in Figure 2C comparison of available data for
Quininde´ with data from the cohort, with respect to mater-
nal-child factors and social indicators (Table 3), showed the
Figure 1. Flowchart illustrating the recruitment and follow-up of the
ECUAVIDA cohort to 5 years of age.
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cohort to be similar with respect to maternal age and ethni-
city, and proportion of male births. A comparison of house-
hold factors show that the cohort households had greater
access to services than the general population in Quininde´,
probably a reflection of recruitment at HPAB and differential
use of this service between urban and rural populations
within the district.
How are they being followed up?
Data collections are being done at baseline during the ini-
tial home visit and at 7, 13, 24, and 36 months and 5 and
8 years of age. Follow-up visits are either scheduled at an
HPAB outpatient facility dedicated for the cohort, or
through home visits. The study population is highly mo-
bile, largely within the district, and detailed information
has been obtained to optimize follow-up—including maps
of the location of the household and mobile telephone con-
tacts for the mother and close neighbours.
What has been measured?
Measurements are done as outlined in Tables 1 and 2. The
primary study outcomes are atopy, eczema and asthma.
Data on eczema are being collected using standardized
instruments based on the UK Working Party (UKWP)
criteria/Nottingham protocol29 and are measured at 3 years
of age. Asthma is measured at 5 and 8 years of age. Atopy
Figure 2. Study site. (A) Map of Ecuador showing location of district of Quininde´, Esmeraldas Province (shaded circle) (courtesy of the General
Libraries, University of Texas at Austin, TX). The recruitment area for the cohort was defined by the geographical boundaries of this district. (B) Map
showing parishes the district of Quininde´ including La Concordia. H, Hospital Padre Alberto Buffoni. (C) geographical location of households of cohort
infants.
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is measured as allergen skin test reactivity at 5 years of age.
Primary study exposures are the presence of maternal STH
infections or presence of STH infections in the child during
the first 2 years of life. Standardized questionnaires collect
data periodically from the mother on socioeconomic,
household and lifestyle factors, demographics, environ-
mental exposures and allergic symptoms in the child—data
collected are detailed in Table 1. Physical examinations are
done at each observation time. Airways function and
reversibility following inhalation of salbutamol, and air-
ways inflammation by FeNO30 and cytology in nasal
washes will be evaluated at 8 years of age. Routine an-
thropometric measures include weight (using digital paedi-
atric scales), length and height (using locally made
infantometers and stadiometers, respectively) and other
measures as listed in Table 2. Blood samples are being col-
lected for routine measurements (haemoglobin and total
white cell and differential counts) and plasma (antibodies
Table 1. Data collected by questionnaire
Variable Birth 7 m 13 m 24 m 36 m 5 yrs 8 yrs
Demographics
Sex of the child þ
Parental age and ethnicity þ
Socioeconomic data
Household income and ownership þ þ
Parental education and occupation þ þ
Household electrical connection/material goodsa þ þ
Household characteristics
Household location/urban vs rural þ þ þ þ þ þ þ
Household crowding þ þ þ þ þ þ þ
Sources of drinking water / disposal of faeces þ þ
House construction þ þ þ
Cooking fuels þ þ
Maternal health and disease
Obstetric history and complications þ
Chronic diseases including allergic þ þ
Vaccines/antibiotics/medications during pregnancy þ
Smoking during pregnancy þ
Child characteristics and exposures
Mode of birth and related factors þ
Gestational ageb þ
Symptoms of wheezing/eczema/rhinitis þ þ þ þ þ þ
Day care þ þ þ þ þ
Pet/farming/animal exposures þ þ þ þ þ þ þ
Environmental tobacco smoke þ þ þ þ þ þ þ
Number of siblings þ þ þ þ þ þ
Morbidity including hospitalizations þ þ þ þ þ þ
Use of medications/antibiotics þ þ þ þ þ þ
Vaccination history þ þ þ þ þ þ
Breastfeeding/weaning/diet þ þ þ þ þ
Allergic symptoms þ þ þ þ þ þ
Psychosocial evaluationsc þ
Food frequency questionnaire þ
Father and siblings
Chronic diseases including allergic þ þ
Urbanization
Variables to measure urbanization þ
All data are collected from the child’s mother or primary carer.
Mo, months; yrs, years.
aFridge, television, hi-fi, radio.
bEstimated from date of last menstrual period.
cData collected with the following instruments: Self Reporting Questionnaire 20 (SRQ-20); Child Behaviour Checklist (CBCL); Perceived Stress Scale (PSS);
Medical Outcomes Study Social Support Scale (MOS-SS); Conflict Tactics Scale Parent-child (CTSPC), Community Violence Questionnaire (CVQ).
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Table 2. Sample collection and clinical and other evaluations
Variable Birth 3 m 7 m 13 m 18 m 24 m 30 m 36 m 5 yrs 8 yrs
Environmental measures
Mattress dust samples þa þ
GPS þa
Clinical measurements
Child
Apgar þb
Clinical examination þ þ þ þ þ þ þ
Weight/height (length) þ þ þ þ þ þ þ
Head and abdominal circumference þ þ þ þ þ þ þ
MUAC/bioimpedance þ þ
Physical activity þc
Evaluation of child allergy
Clinical examination for flexural dermatitis þ þ þ þ þ þ
Allergen skin prick test reactivityd þ þ þ þ
Pulmonary functionþ reversibility with b2 agonist þ
FeNO þ
Nasal wash þ
Sample collection in child
Cytokine responses
Innate þe þe þe þe þe þe
Adaptive þe þ þ þ þ þ þe
Whole blood RNA þe þe þe
Cell population studies þe þe þe þe
Plasma/Hb/differential/DNA þe þ þ þ þ þ þ
Faeces (parasites/DNA) þ þf þ þ þf þ þf þ þ þ
Hypo- and nasopharyngeal swabs þe þe þe þe þ þ
Mother
Plasma/Hb/differential/DNA þ
Cell culture (innate/adaptive) þe
Whole blood RNA þe
Cell populations þe
Weight/height/bioimpedance/MUAC þ þ
Allergen skin prick test reactivityg þ
Glucose þh þ þ
Blood pressure þ þ
Faeces (parasites/DNA) þ
Father
Plasma/Hb/differential/DNA þ
Allergen skin prick test reactivityg þ
Faeces (parasites) þ
Weight/height/bioimpedance/MUAC þ þ
Glucose þ þ
Blood pressure þ þ
Household members
Faeces (parasites) þ
Italics represent stored samples.
MUAC, mid-upper arm circumference.
aRepeated each time there is change of address.
bData available for births in HPAB.
cPlanned for a sample of the cohort using 7-day triaxial accelerometer.
dSaline control, histamine, Dermatophagoides pteronyssinus/farinae, American cockroach, fungi mix, mosquito, dog, cat, peanut, milk, egg, and mixed grass pollen.
eSample of 295 children and their mothers for more detailed immunological evaluations.
fPassive collections.
gSaline control, histamine, Dermatophagoides pteronyssinus/farinae, American cockroach, fungi mix, mosquito, dog, cat, Alternaria, Blomia tropicalis,
Chortoglyphus, and mixed grass pollen.
hFrom antenatal records at HPAB where available.
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including IgE) and buffy coats (DNA) are being stored.
Peripheral blood leukocytes are also being stimulated with
various innate and adaptive immune stimuli to measure
cytokine and chemokine responses (Table 2).31 Stool sam-
ples for detection of enteric parasites are collected from the
mother and from the child as shown in Table 2. Samples
were also collected from children providing a stool sample
at additional sampling times: at 3 (samples from 1294 chil-
dren), 18 (1020) and 30 (640) months, without active
chasing-up of samples. Stool samples for the detection of
enteric parasites are examined using a combination of tech-
niques including direct saline mounts, the modified Kato-
Katz method, formol-ethyl acetate concentration,32 and in
samples by carbon coproculture33 and real-time polymer-
ase chain reaction (PCR).34 An aliquot of stool from each
sample is being stored for later analysis of intestinal bacter-
ial microbiota as described.35 Nasopharyngeal (NP) swabs
have been collected for detection of respiratory viral infec-
tions and oropharyngeal swabs for analysis of upper air-
ways bacterial microbiota36 at routine observation times
and when the child presents to the ECUAVIDA outpatient
clinic with respiratory symptoms including wheeze.
Within the cohort, we have done active surveillance
with twice-weekly sampling for respiratory tract infections
and diarrhoea in a sample of 195 children between birth
and 3 years of age. These samples will be analysed for the
presence of respiratory viral infections (NP swabs) and
enteric viruses and parasites (stools). Cohort children pre-
senting to ECUAVIDA outpatient clinic with fever have
been sampled for blood to measure pathogens over 3 calen-
dar years between 2012 and 2014. Dietary consumption
of the child is being evaluated using a food-frequency ques-
tionnaire when the child is 6–7 years. Questionnaires are
being administered to the child’s mother when the child is
4–6 years, to evaluate pyschosocial factors including:
(i) Self-Reporting Questionnaire [SRQ-20] developed by
WHO37 and being used to measure minor psychiatric dis-
orders in the mother;38 (ii) Child Behaviour Checklist
(CBCL) to assess behavioural problems in the child:39,40
(iii) Perceived Stress Scale (PSS) to measure the perception
of stress by the mother;41 (iv) Medical Outcomes Study
Social Support Scale (MOS-SS) to measure social support
of the mother within the community;42,43 (v) Conflict
Tactics Scale Parent-Child (CTSPC) to measure psycho-
logical and physical maltreatment and neglect of children
by parents;44 (vi) Community Violence Questionnaire
(CVQ) to measure parental exposures to community
violence.45
What has it found?
The ECUAVIDA cohort forms part of a Latin American
research collaboration called SCAALA (Social Changes,
Asthma, and Allergies in Latin America) that includes
two prior studies: SCAALA-Salvador46 and SCAALA-
Esmeraldas.47 SCAALA-Salvador is based on a cohort set
up in urban neighbourhoods of Salvador, that has been
investigating risk factors for allergic diseases within which
most analyses have been cross-sectional; whereas
SCAALA-Esmeraldas is a cross-sectional study done in
Esmeraldas Province, Ecuador, among urban and rural
schoolchildren with similar objectives. Many of the meth-
odologies and instruments developed for the SCAALA
studies are being used in the ECUAVIDA cohort, and
hypotheses generated by these studies are being tested in
the ECUAVIDA cohort in a prospective manner using a
wider range and/or more refined set of instruments.45,48,49
Key findings from SCAALA-Esmeraldas to date include
the observations that: poor hygiene exposures (e.g. STH in-
fections) were associated with a reduced prevalence of SPT
but not of eczema-asthma-rhinitis symptoms; and recent
wheeze although reasonably frequent in rural schoolchil-
dren (10%), was mild, did not require medication for
control and was not strongly associated with atopy (this
association was stronger in urban than rural schoolchil-
dren).10 STH infections did not protect against allergic
symptoms, but allergic sensitization to Ascaris was a major
risk factor for recent wheeze in rural schoolchildren.50 The
ECUAVIDA cohort provides the opportunity to
Table 3. Comparison of ECUAVIDA cohort with population in
district of Quininde´, Esmeraldas Province, Ecuador, by mater-
nal and child factors and social indicators
Factor ECUAVIDA
Cohort (N¼2404)
District
population
Maternal factors
Maternal age (median)57 24 years 26 years
Ethnicity58
Afro-Ecuadorian 25.6% 24.7%
Mestizo 74.0% 72.6%
Indigenous 0.4% 2.7%
Child
Male births57 51.1% 52.6%
Household factors58
House ownership 51.0% 61.1%
Potable water 34.3% 16.0%
Crowdinga 58.9% 22.1%
Sewage connection 29.8% 10.1%
Electricity 96.0% 83.6%
Cooking materials
Gas 99.6% 91.6%
Charcoal/wood 2.8% 6.9%
The sample size for district-level information varies by data source.
aCrowding defined as >3 people per sleeping room.
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understand better the link between STH and other micro-
bial and non-microbial exposures in early childhood, and
the development of atopy and allergic diseases.
The ECUAVIDA cohort represents the section of the
population of the district that relies on and has access to the
public health service and has a relatively low mean house-
hold monthly income of US$209, equivalent to the basic
monthly wage over the period 2006 to 2009. The majority
of mothers had completed primary (58.7%) but not second-
ary education (26.0%). The population is undergoing a
rapid transition from a traditional to a more modern urban
lifestyle—approximately half (51.8%) of the mothers had
substantial farming exposures during pregnancy, indicating
continuing links with a more rural lifestyle, and over half
(53.3%) had received at least one course of antibiotics dur-
ing pregnancy. The primary study exposures were frequent:
almost half (45.9%) of the mothers were infected with
STH parasites, mainly with A. lumbricoides and T. trichiura,
of which most infections were of light intensity according
to WHO criteria.51 Infections with hookworm and S. ster-
coralis were of low prevalence among mothers. High rates
of infection with STH parasites were observed in cohort
children during the first 3 years of life, that is 28.6% of
cohort children by 2 years (Table 4) and 42.3% by 3
years.52 Maternal STH infections during pregnancy were
strongly associated with childhood STH infections, particu-
larly among children of mothers with moderate to high
infection intensities with A. lumbricoides, and point to a
potential and novel intervention strategy for the prevention
of STH infections in pre-school children: the targeted treat-
ment of women of childbearing age.52
With our collaborators, we developed PCR-based diag-
nostic stools to increase sensitivity for the detection of en-
teric faecal parasites, both helminth and protozoal, in the
cohort. In a random sample of 400 children at 13 months,
we detected Cryptosporidium spp. in 5.3% of children,
Giardia lamblia in 31.5%, and Entamoeba histolytica in
1.0%.34 The corresponding infection rates for the same
children at 36 months were 15.4, 45.6% and 2.2%, re-
spectively, indicating high rates of infection with
Cryptosporidium spp. and G. lamblia in our study popula-
tion. Similarly, within the active surveillance sub-sample,
we have estimated incidence rates with norovirus infec-
tions (GI and GII genotypes) during the first 3 years of
life: 0–5 months, 5.2 infections/100 person-years; 6–11
months, 75.7; 12–23 months, 63.8; and 24–36 months,
49.1. Similar analyses are being done for rotavirus infec-
tion and the common respiratory viral infections. Such
data, in the wider study, will allow us to evaluate if a
higher incidence of early childhood infections, either with
individual infections or a combination of infections, affect
the study outcomes.
Study outcomes to 3 years of age were reasonably com-
mon: any episode of eczema was observed in 17.7% and
wheeze in 25.9% of 2069 children with complete follow-
up data, whereas 17.1% of 2212 children evaluated at 3
years of age had skin test reactivity to any allergen (Table
4). Immunological analyses done in the cohort have pro-
vided evidence for in utero sensitization to Ascaris infec-
tions among newborns of mothers with ascariasis: higher
frequencies of CD4þ T cells expressing IFN-c and IL-4 in
cord blood from newborns of infected mothers compared
Table 4. Prevalence of study exposures and outcomes by 3
years of age in ECUAVIDA cohort children
Exposure Measure Outcome
Maternal STH infections (N¼2390)
Any % (N) 45.9 (1,098)
Ascaris lumbricoides
Prevalence % (N) 28.0 (668)
Intensity GM (range) 683 (35–109, 760)
Trichuris trichiura
Prevalence % (N) 28.7 (687)
Intensity GM (range) 22 (35–30, 660)
Hookworm % (N) 5.8 (139)
Strongyloides stercoralis % (N) 4.0 (96)
Other helminth infectionsa % (N) 0.5 (13)
STH infections during first 2 years in child (N¼2224)
Any % (N) 28.6 (635)
Ascaris lumbricoides % (N) 22.3 (496)
Trichuris trichiura % (N) 12.3 (273)
Hookworm % (N) 0.4 (9)
Strongyloides stercoralis % (N) 0.8 (18)
Other helminth infectionsa % (N) 0.9 (20)
Prevalence of study outcomes by 3 years of age
Eczema (N¼2069)
Any episode % (N) 17.7% (367)
Recurrent % (N) 2.5% (52)
Wheeze (N¼2069)
Any episode % (N) 25.9% (536)
Recurrent % (N) 7.1% (146)
Skin prick test reactivityb (N¼2212)
Any allergen % (N) 17.1% (378)
Any aeroallergen % (N) 15.2% (337)
D. pteronyssinus/farinae % (N) 8.4% (186)
American cockroach % (N) 3.0% (67)
Fungi % (N) 2.5% (55)
Dog % (N) 2.4% (53)
Cat % (N) 1.1% (25)
Grass % (N) 2.4% (53)
Any food allergen % (N) 3.5% (78)
Peanut % (N) 1.2% (27)
Milk % (N) 1.2% (27)
Egg % (N) 1.8% (39)
STH, soil-transmitted helminth; recurrent, 2 or more episodes.
aHymenolepis sp.
b2-mm cutoff.
1524 International Journal of Epidemiology, 2015, Vol. 44, No. 5
with those of uninfected mothers.53 Further, cord blood
from newborns of infected mothers had higher levels of the
immune modulatory cytokine, IL-10, compared with those
of uninfected mothers.54
Together these data suggest that maternal STH infec-
tions can sensitize the foetus in utero, presumably through
trans-placental transfer of parasite antigens from the ma-
ternal circulation, and that such infections are associated
with immune regulation, supporting the hypothesis that
early STH exposures promote immune regulation in the
child. Our observation that maternal STH infections were
associated with an increased susceptibility to STH infec-
tions in the offspring52,54 implies that such toleration could
increase the risk of infection in the child. Regional differ-
ences in the risk of inflammatory diseases and immune re-
sponses to infections and vaccines could be explained by
differences in innate immunity. To determine if innate im-
mune responses in 2-year-old children differ geographic-
ally, we have compared innate immune responses to
pattern recognition receptor stimuli in a sample of 42 chil-
dren from the cohort at 2 years of age, with the same re-
sponses in 2-year-olds from Belgium, Canada and South
Africa.55 Innate responses in Ecuadorian children were sur-
prisingly similar to those in Belgian and Canadian children,
with only South African children having markedly lower
responses overall.55 Pyrosequencing comparing the upper
airways bacterial microbiota of 24 infants from the cohort
with early-onset wheezing, with 24 non-wheezing con-
trols showed a microbiota among wheezers with increased
presence of pathogens such as Haemophilus and
Staphylococcus spp.36
What are the main strengths and
weaknesses of the study?
A major problem with prospective studies is losses to fol-
low-up. Losses have been complicated by high rates of
internal migration within the study area, among a highly
mobile population. To date, 63% (1504/2404) children
have changed address at least once and some children have
changed address up to seven times. However, despite such
logistic challenges, we have been able to maintain a high
rate of follow-up after 7 months. We were only able to
evaluate 72.3% of children at 7 months because of logistic
restraints of doing multiple follow-ups simultaneously in a
cohort that took 4 years to recruit and where the number
of contacts made during the 1st year was probably too fre-
quent for the resources at our disposal. New procedures
were put in place to ensure the higher follow-up of 93.0%
achieved at 13 months. Such procedures included the set-
ting up a dedicated team for registering changes of address
and locating mothers prior to each scheduled follow-up
visit, and the collection of more extensive data on family
and neighbourhood contacts with mobile telephone num-
bers. All cohort children had reached 3 years of age by
December 2012. Follow-up is shown in Figure 1 and was
93.3% at 3 years of age. Follow-up at 5 years of age is
ongoing and the 8-year evaluation will start in 2014. We
anticipate a high rate of follow-up at 5 and 8 years of age.
A second limitation was the collection of a maternal
stool sample around the time of birth up to 14 days after
delivery. At the time of the study, a minority of pregnant
mothers attended antenatal clinics at HPAB. We believe
that stools collected at this time do represent infections
during the third trimester because STH infections are
chronic, with adult parasites capable of surviving for sev-
eral years in the human intestinal tract. Anthelmintic treat-
ment was offered to infected mothers after the birth of the
child. We have only limited data on the prenatal period
and no measurements of lung function during early
childhood.
Another weakness is the reliance on maternal recall for
collection of data by questionnaire, which could lead to
recall bias because of differential recall depending on ma-
ternal age and educational level.
Important strengths are the high rate of follow-up,
the large number of repeated measurements and the wide
range of infectious and other environmental exposures
being measured. The primary exposure of STH infections
is being measured using objective, highly specific and rea-
sonably sensitive methods that we have expanded now to
more sensitive and specific PCR-based methods in nested
samples. The post-neonatal mortality rate observed in the
cohort (5.4 deaths/1000 live births) was lower than ex-
pected for a low-income setting—the national rate in
Ecuador was 10 per 1000 live births in 201156—and prob-
ably reflects a combination of recruitment of healthy
infants and improved survival by participation in an in-
tensely studied cohort with continuous access to health
practitioners.
The study area is a mixture of urban, peri-urban and
rural populations, all of which, to a greater or lesser ex-
tent, are undergoing urbanization. This should provide
valuable insights into the effects of processes associated
with urbanization on the development of allergic disease.
Can I get hold of the data? Where can I find
out more?
The data set is not presently freely available but will be
made so in the future through an interactive website for
the cohort, which will allow interested researchers to make
requests for data access. We also welcome specific queries
and proposals for collaboration, which should be directed
International Journal of Epidemiology, 2015, Vol. 44, No. 5 1525
to the corresponding author (pcooper@sgul.ac.uk). Data
access is provided on request (pcooper@sgul.ac.uk).
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